Last updated 16 days ago

A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma

733 patients around the world
Available in Spain, Chile, United States
Regeneron Pharmaceuticals
1Research sites
733Patients around the world
This study is for people with
Non-Hodgkin Lymphoma
Follicular lymphoma
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Clínica Universidad de los Andes
Recruiting
Av Plaza 2501, Las Condes, Región Metropolitana, Santiago
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy